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Abstract
Tourette syndrome (TS) is a neurodevelopmental condition characterised by tics, which are stereotyped movements and/or 
vocalisations. Tics often cause difficulties in daily life and many with TS express a desire to reduce and/or gain control over 
them. No singular effective treatment exists for TS, and while pharmacological and behavioural interventions can be effective, 
the results are variable, and issues relating to access, availability and side effects can be barriers to treatment. Consequently, 
over the past decade, there has been increasing interest into the potential benefits of non-invasive brain stimulation (NIBS) 
approaches. This systematic review highlights work exploring NIBS as a potential treatment for TS. On balance, the results 
tentatively suggest that multiple sessions of stimulation applied over the supplementary motor area (SMA) may help to 
reduce tics. However, a number of methodological and theoretical issues limit the strength of this conclusion, with the most 
problematic being the lack of large-scale sham-controlled studies. In this review, methodological and theoretical issues are 
discussed, unanswered questions highlighted and suggestions for future work put forward.
Keywords Transcranial magnetic stimulation (TMS) · Transcranial direct current stimulation (tDCS) · Theta burst 
stimulation (TBS) · Supplementary motor area (SMA) · Tourette syndrome (TS) · Tics
Introduction
In this systematic review, we explore the topic of non-
invasive brain stimulation (NIBS) as a potential treatment, 
or adjunct to treatment, to help people with Tourette syn-
drome (TS) to reduce their tics. We consider the existing 
treatment options for TS, the justification and scientific rea-
soning behind using NIBS in this clinical group, and review 
the evidence to date. We also consider some limitations of 
frequently used therapeutic NIBS approaches and make 
suggestions for how this might usefully progress in the field 
of TS and beyond.
Tourette syndrome
Tourette syndrome (TS) is a neurodevelopmental dis-
order that is found in the majority of cultures worldwide 
(Robertson et  al. 2009). It affects approximately 1% of 
5–18 years old (Cohen et al. 2013) and is approximately 
five times more common in males than females within this 
age group (Lichter and Finnegan 2015). TS is characterised 
by the occurrence of tics, which are repetitive, stereotyped 
movements and/or vocalisations of short duration, which 
can occur many times throughout a day. In some instances, 
motor tics can be physically painful and result in injury due 
to their strong and repetitive nature; tics can attract unwanted 
attention and be distressing. While tics, and the way that 
individuals cope with them are varied, they can influence 
many aspects of daily life including social, occupational/
academic, and psychological well-being of both adults and 
children (Conelea et al. 2011, 2013). Consequently, many 
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individuals with a diagnosis of TS will seek out strategies to 
minimise the occurrence of, or gain control over, their tics.
There are several factors which make developing effective 
treatments for TS challenging. First, the biological under-
pinnings of this condition are complex, multi-faceted, and 
not fully understood. TS rarely presents in isolation, and the 
majority of individuals with TS also meet the diagnostic cri-
teria for at least one other neuropsychiatric condition, with 
the most prevalent co-morbidities being obsessive compul-
sive disorder (OCD) and attention deficit hyperactivity dis-
order (ADHD) (Wright et al. 2012). Subtly different changes 
in brain structure and function are likely to underlie these 
different symptom profiles, which in turn may influence 
response to therapeutic interventions. Sample sizes are often 
too small to thoroughly investigate this in humans; how-
ever, research in animals has compellingly linked region-
ally specific disruption in the striatum to tic-like behaviours, 
compulsions, and hyperactivity (see Bronfeld et al. (2013) 
for review).
Another challenge in developing treatments for TS is 
the practical and ethical considerations associated with the 
treatment of children/adolescents. For example, behavioural 
interventions often require a level of sustained attention and 
introspection, which can be difficult for younger children. 
There are also complex issues surrounding medication use 
in this age group, including consideration of potential side 
effects and the impact of sustained medication use on the 
developing brain. These issues are compounded by the fact 
that there is relatively little known about the developmental 
trajectory of this disorder, and it is unclear why some indi-
vidual's tics reduce with age (Bloch and Leckman 2009), 
while for others, they do not.
Treatment options for Tourette syndrome
Despite the numerous challenges, a number of tic reduc-
tion/management approaches are available. At present, the 
most common forms of treatment for tics are medication and 
behavioural therapy.
Habit reversal therapy (HRT) (Azrin and Nunn 1973) 
and extensions of this, such as comprehensive behavioural 
intervention for tics (CBIT) (Piacentini et al. 2010), are tic 
focused, and involve raising an individual’s awareness of 
sensory experiences prior to a tic and then encouraging the 
use of subtle, incompatible movements/vocalisations to 
be voluntarily executed until the need to tic reduces. Both 
HRT and CBIT are dependent on individuals being able to 
recognise subjective sensations often called premonitory 
urges (PU). PU are often described as feelings of discom-
fort or pressure prior to a tic, and are experienced by the vast 
majority of people with TS as an urge-to-tic (Bliss 1980). 
However, the experience of PU appears to vary with age 
and tic severity—in that older individuals and those with 
stronger tics have reported higher rates of PU (Sambrani 
et al. 2016). Interestingly, while both treatments have been 
found to be effective (Bate et al. 2011; Dutta and Cavanna 
2013; McGuire et al. 2014), and appear to be dependent on 
the link between PU and tics, the evidence linking the two 
is inconclusive (Ganos et al. 2012) and much debated within 
the field (Cavanna et al. 2017; Jackson et al. 2011). Unfor-
tunately, these types of therapy are not suitable or effective 
for all individuals, and access to specialists who are able to 
provide this treatment is often limited and remains an issue 
for many (Cuenca et al. 2015; Hollis et al. 2016). As a result, 
a common alternative to behavioural therapy is pharmaco-
logical treatment.
A systematic review found that over half of young people 
with TS had received medication to help with their tics (Hol-
lis et al. 2016). While there is no single drug that directly tar-
gets tics, a range of medications can be effective in helping 
to reduce them. These include antipsychotics such as halop-
eridol which work by blocking D2 dopamine receptors, and 
alpha agonists such as clonidine which inhibit the release of 
noradrenaline (Kurlan 2014). Other drugs commonly pre-
scribed to treat TS include atypical antipsychotics such as 
risperidone and aripiprazole (Hollis et al. 2016). Unfortu-
nately, the side effects of these medications can outweigh the 
benefits for many individuals, as they include weight gain, 
stomach irritation, drowsiness, and sleep disturbances [see 
Hollis et al. (2016) for review].
For individuals who have disabling and treatment-resist-
ant tics, deep brain stimulation (DBS) can be highly effec-
tive. Direct implantation of electrodes to regions of the basal 
ganglia, including the globus pallidus, the nearby internal 
capsule, or the centromedian nucleus of the thalamus, have 
been shown to substantially reduce tics, and can also reduce 
symptoms of co-morbid conditions such as OCD (Balder-
mann et al. 2016; Coulombe et al. 2019). However, this 
approach involves invasive brain surgery and its associated 
risks. There are also ethical considerations regarding the 
use of this type of intervention in children (Hedderly 2017; 
Servello et al. 2016), and again, there is very limited access 
to this form of treatment.
Other treatments include psychoeducation (Nussey et al. 
2013), relaxation training (Bergin et al. 1998), and the use 
of botulinum toxin (Pandey et al. 2018), and have varying 
levels of effectiveness and various strengths and challenges 
when considering costs and benefits to individuals [for 
review, see Hollis et al. (2016)].
More recently, non-invasive brain stimulation (NIBS) has 
also been explored as a potential treatment for tics. NIBS 
possesses several possible advantages over other approaches. 
Given proper administration and monitoring, NIBS is largely 
free of adverse or side effects. NIBS can be used at rest 
without the need for cognitively demanding tasks (such 
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as continuously monitoring PU) and can be used to non-
invasively target-specific cortical regions associated with the 
pathophysiology of a condition. However, as will be dis-
cussed in the following sections, therapeutic use of NIBS has 
its own complexities, limitations, and areas for development.
Non‑invasive brain stimulation as a potential 
therapeutic intervention
The first studies exploring the use of NIBS as a potential 
therapeutic intervention for tics were conducted in the early 
2000s. Since then, there has been a small but steady increase 
in studies exploring the therapeutic potential of forms of 
NIBS such as repetitive transcranial magnetic stimulation 
(rTMS) and transcranial direct current stimulation (tDCS).
Brief introduction to rTMS and theta burst 
stimulation (TBS)
Transcranial magnetic stimulation (TMS) is a non-invasive 
brain stimulation technique that was first reported in 1985 
(Barker et al. 1985). During stimulation, a brief but strong 
electrical current is delivered from an electrical capacitor to 
the TMS coil which contains conductive windings of wire. 
When an electrical current is present, a fluctuating magnetic 
field perpendicular to the coil is generated. The resultant 
magnetic fields can pass painlessly through the scalp and 
skull and induce an electrical current on the cortical surface. 
This induced current can then influence electrical signaling 
of neuronal populations. In particular, it can depolarize neu-
rons or their axons (Hallett 2000). At present, the most com-
monly used TMS method for therapeutic neuro-modulation 
in patients with TS is rTMS, including a patterned version 
of this known as theta burst stimulation (TBS). Early rTMS 
studies typically involved exploring the effects of stimula-
tion applied to the motor cortex by assessing changes in 
motor-evoked potentials (MEPs) (Chen et al. 1997; Pascual-
Leone et al. 1994). The consensus from these and numer-
ous subsequent studies is that low frequency rTMS (1 Hz) 
tends to lead to a reduction in cortical excitability (indexed 
by smaller MEPs), whereas higher frequencies (typically 
5–20 Hz) are more often associated with faciliatory effects 
on corticospinal output (larger MEPs). While this is the gen-
eral trend, it should be noted that substantial individual vari-
ability in response to these protocols is often observed, with 
differences in both the magnitude and direction of effects 
reported (Maeda et al. 2000).
TBS is a patterned form of rTMS, in which bursts of 3 
TMS pulses at 50 or 30 Hz are delivered at a rate of 5 Hz. 
This patterned stimulation can be delivered either in a con-
tinuous (cTBS) or intermittent (iTBS) fashion (Huang et al. 
2005). As with rTMS, it appears that both facilitation and 
inhibition of MEP amplitudes are possible following TBS 
stimulation, with cTBS reported to typically have a net 
inhibitory effect, while iTBS tends to result in net increased 
cortical excitability. However, as is the case for other forms 
of rTMS, both inter- and intra-individual variability has been 
reported in response to TBS (Lopez-Alonso et al. 2014; 
Ozdemir et al. 2021; Vallence et al. 2015).
Changes in cortical excitability, as indexed by alterations 
in MEP amplitude, suggest that the effects of a single ses-
sion of rTMS and TBS can last over 30 min [for example: 
Jung et al. (2008); Wischnewski and Schutter (2015)]. These 
sustained aftereffects are frequently referred to as reflect-
ing long-term potentiation (LTP) and long-term depression 
(LTD) like changes, which are likely caused by alterations 
in synaptic transmission. While this may be a slight over-
simplification (see Lefaucheur et al. (2014) for discussion), 
it is nonetheless clear that the effects of such protocols can 
outlast the stimulation period, rendering them interesting as 
potential therapeutic interventions for TS.
Brief introduction to tDCS
Another NIBS technique with potential as a treatment for 
tics is transcranial direct current stimulation (tDCS). TDCS 
involves running a low voltage current (typically between 
1 and 2 mA) between a minimum of two electrodes, at 
least one of which is placed on the scalp. Like rTMS/TBS 
approaches, tDCS in healthy adults has been shown to 
induce changes in cortical excitability outlasting the stimu-
lation period. The exact neurobiological mechanisms under-
pinning tDCS effects are not fully understood, but in general, 
it is accepted that effects during stimulation are likely related 
to alterations in membrane potential, whereas the aftereffects 
appear to be dependent on alteration to N-methyl-d-aspartate 
(NDMA) (Liebetanz et al. 2002; Nitsche et al. 2003) and 
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA) (Martins et al. 2019; Stafford et al. 2018) receptor 
channels. Changes in levels of the inhibitory neurotransmit-
ter gamma-aminobutyric acid (GABA) following tDCS have 
also been observed (Nitsche et al. 2004; Stagg et al. 2009). 
Typically, regions underneath the anode show a temporary 
increase in cortical excitability, reflected in increased MEP 
amplitude, whereas the opposite is true for areas under the 
cathode. As with rTMS and TBS, the patterns of response 
to stimulation vary, and substantial inter- and intra-subject 
variability in response to tDCS have been demonstrated 
(Dyke et al. 2016; Horvath et al. 2016; Wiethoff et al. 2014).
tDCS has some practical advantages over TMS. Specifi-
cally, it is relatively cheap to purchase, easy to adminis-
ter, and is increasingly being explored as an intervention 
that is suitable for home administration for several condi-
tions (Palm et al. 2018). However, this technique is less 
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established, particularly in terms of therapeutic use in the 
treatment of TS.
Identifying stimulation sites
One of the most important practical considerations in devel-
oping NIBS as an effective therapy is to identify appropriate 
sites for stimulation. While the exact underlying neurobiol-
ogy of TS is not fully understood, dysfunction within cor-
tical–striatal–thalamic–cortical (CSTC) circuits have been 
heavily implicated in the pathophysiology of tic disorders 
(Greene et al. 2015; Mink 2006). Many of the regions impli-
cated (including the areas of the basal ganglia targeted by 
DBS) cannot be directly reached using NIBS, due to the 
restricted depth penetration of induced (rTMS/TBS) and 
direct weak electrical currents (tDCS). However, studies 
combining Magnetic Resonance Imaging (MRI) with TMS 
have revealed changes in blood-oxygenation-level-depend-
ent (BOLD) in cortical and subcortical regions connected 
to the stimulation site (for review, see Fox et al. (2012)). 
For example, stimulation of the sensorimotor cortex using 
rTMS has been shown to induce BOLD changes in deeper 
structures such as the basal ganglia via inter-connected neu-
ral pathways (Bestmann et al. 2004, 2005). tDCS has also 
been shown to alter BOLD activity in regions which are 
functionally connected to the targeted cortical site of stimu-
lation, (Saiote et al. 2013), with at least one study suggesting 
that modulation of deep structures such as the thalamus is 
possible (Polania et al. 2012). Consequently, NIBS methods 
for treating tics have centred on the idea of reducing cortical 
excitability within regions such as the supplementary motor 
cortex (SMA) and primary motor cortex (PMC), while also 
aiming to increase the engagement of inhibitory circuits and 
take advantage of connectivity between cortical regions and 
relevant deeper structures.
The SMA is a particularly appealing target site for thera-
peutic stimulation due to its role in modulating descending 
corticospinal projections, its likely involvement in tic pro-
duction, and evidence of structural and functional alterations 
in TS. The SMA has extensive connections to areas relating 
to motor control and cognitive processing (Picard and Strick 
2001), and work in primates has demonstrated SMA involve-
ment in neural networks connecting cortical, thalamic, and 
basal ganglia pathways (Haber 2003); regions which are all 
heavily implicated in TS. The SMA of individuals with TS 
has been shown to exhibit altered metabolic activity (Eidel-
berg et al. 1997) and increased concentrations of the inhibi-
tory neurotransmitter GABA (Draper et al. 2014). It has 
also been shown to be active immediately prior to tic onset 
(Bloch et al., 2016a; Bohlhalter et al. 2006; Hampson et al. 
2009). The white matter pathways connecting the striatum 
and thalamus with PMC and SMA have been reported to be 
increased in TS, in a manner which correlates positively with 
symptom severity (Worbe et al. 2015). Furthermore, SMA 
connectivity to PMC during self-paced finger movements is 
altered in TS (Franzkowiak et al. 2012) and differences in 
patterns of activation in SMA/pre-SMA have been shown 
during Go/NoGo (Thomalla et al. 2014) and stop signal 
tasks (Ganos et al. 2014) relative to healthy controls.
Due to its prominent role in the motor system, direct tar-
geting of the primary motor cortex (PMC) is another logical 
stimulation site for the therapeutic treatment of TS using 
NIBS approaches. The justification for this is largely based 
on work which suggests that at rest there is reduced inhibi-
tion within this area. This has typically been assessed by 
measuring short-interval intra-cortical inhibition (SICI). 
SICI is a paired pulse TMS technique in which a subthresh-
old conditioning pulse is applied to the motor cortex 1–5 ms 
prior to a supra (i.e., above) threshold test pulse. The first 
pulse modulates the effects of the second, typically caus-
ing a reduction in motor-evoked potentials when compared 
to those generated by the test pulse alone. SICI has been 
reported to be reduced in adults with TS (Heise et al. 2010; 
Orth et al. 2005, 2008; Orth and Rothwell 2009; Ziemann 
et al. 1997) and to correlate with motor tics and ADHD 
symptoms in both children and adults (Gilbert et al. 2004, 
2005). Animal models and pharmacological studies have 
suggested that the effects of SICI are strongly mediated by 
GABAergic activity, with emphasis on the involvement of 
GABA-A receptors (Hanajima and Ugawa 2008; Ziemann 
2013), and a minor contribution from GABA-B receptors 
(McDonnell et al. 2006). Hence, these findings suggest 
that GABAergic synaptic inhibition within primary motor 
regions is reduced in TS.
Theoretically, it may be possible to alter the balance of 
excitation/inhibition within cortical regions such as the 
SMA and PMC using repeated application of NIBS. Spe-
cifically, as the majority of previous research suggests that 
these regions are overly responsive in TS, researchers have 
used approaches which when assessed in healthy adults have 
been reported (on average) to reduce cortical excitability 
(cathodal tDCS, cTBS, and 1 Hz rTMS).
Systematic review of the literature
Search strategy
The approach to systematic review was informed by the 
guidelines outlined in the preferred reporting items for sys-
tematic review and meta-analysis (PRISMA) (Page et al. 
2021) (Fig. 1).
We searched PubMed and Embase using the follow-
ing key terms and Booleans: (‘tic’ OR ‘Tourette*’ OR ‘tic 
disorder’) AND (‘transcranial magnetic stimulation’ OR 
‘theta burst stimulation’ OR ‘transcranial direct current 
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stimulation’ OR ‘transcranial alternating current stimula-
tion’ OR ‘transcranial random noise stimulation’ OR ‘TMS’ 
OR ‘tDCS’). This search was carried out without search 
restrictions from the first date available until 30th June, 2021 
(including articles only available online at the time of the 
search).
Eligibility criteria
The studies included in the review had to meet the following 
criteria: (a) participants must have Tourette’s, tics, or tic dis-
order; (b) a form of non-invasive brain stimulation must have 
been used; (c) outcome measures must include a measure of 
change in tics (e.g., YGTSS or video recording) before and 
at least once after stimulation; (d) an English version of the 
article must be available.
The following types of entry were excluded: (a) reviews; 
(b) animals studies; (c) conference abstracts/presentations; 
(d) studies in which > 50% of participants did not complete 
trial. Letters to editor and case studies were included, pro-
viding that they met the other criteria.
Information extraction
The following information was extracted from studies 
meeting the eligibility criteria: study type (open label, ran-
domised control, and cross over); participant demographics 
(number, age, sex, and diagnosis); NIBS method (stimula-
tion type, are of stimulation, pulse type/intensity); number 
of sessions tested; measurement(s) used to assess symptom 
change; key findings and statistics. Information extraction 
and assessment of articles for inclusion was completed inde-
pendently by KD without use of automation tools.
Results of systematic review
In total, our search criteria yielded 333 articles. Duplicates 
from the two sources were manually identified and removed 
(n = 82) leaving a sample of 251 records to be screened. 
The lead author (KD) screened the titles and abstracts of 
the remaining articles using the eligibility criteria, which 
resulted in 24 articles for retrieval. Of these, a further 6 were 
excluded; 5 as they did not involve pre/post measures of tic 
change (Marsili et al. 2017; Sun et al. 2020; Suppa et al. 
2011; Suppa et al. 2014; Wu and Gilbert 2012) and 1 addi-
tional case study as the participant withdrew early (Salatino 
et al. 2014).
The authors were aware of a further two articles (Car-
valho et al. 2015; Tajadini et al. 2018) which were not iden-
tified in the systematic review, but are nevertheless relevant 
to this topic. Inclusion of these two articles takes the total 
sample size up to 20, of which 13 studies used rTMS/TBS 
(Table 1) and 6 used tDCS. It should be noted that two pub-
lications (Munchau et al. 2002; Snijders et al. 2005) relate 
to the same study and hence are summarised together in 
Table 1.
Fig. 1  Schematic of systematic 
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PubMed (n = 130) 
Embase (n = 203) 
Records removed before screening: 
Duplicate records removed (n = 82) 
Records screened 
(n = 251) 
Records excluded 
(n = 215) 
Conference abstract only (n = 8) 
Conference abstract of published study (n = 4)
Reports sought for 
retrieval 
(n = 24) 
Reports not retrieved 
(n = 0) 
Reports assessed for 
eligibility 
(n = 24) 
Reports excluded: 
No measure of tic change pre/post (n = 5) 
>50 sample didn’t complete (n=1) 
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Evidence so far: rTMS and TBS as a treatment 
for tics
The measures used to assess changes in tics following NIBS 
vary from study to study, with one general exception—the 
Yale Global Tic Severity score [YGTSS (Leckman et al. 
1989)]. The YGTSS is a semi-structured interview used 
to rate the number, frequency, intensity, complexity, and 
interference of the motor and phonic tics experienced by 
an individual in the past week. The scale is commonly used 
within clinical assessment of, and research into TS, and has 
been shown to have good psychometric properties (Leck-
man et al. 1989; Storch et al. 2005). The following sections 
primarily focus on change in tics as assessed by YGTSS 
scores, specifically total tic severity score which is calcu-
lated from the sum of the subscales. A more extensive sum-
mary of the effects of NIBS on other measures including 
assessment of common co-morbidities using the Yale-Brown 
Obsessive Compulsive scale [Y-BOCS (Scahill et al. 1997)] 
and Attention Deficit Hyperactivity Disorder Rating Scale 
[ADHD_RS (DuPaul et al. 1998)] can be found in Tables 1 
and 2.
Several studies have reported significant reductions in 
YGTSS scores (indicating reduced tic severity) follow-
ing rTMS/TBS stimulation applied bilaterally to the SMA 
using pulse configurations associated with reducing cortical 
excitability (e.g., 1HZ rTMS at 100–110% RMT). One such 
study conducted by Kwon et al. (2011) reported significantly 
reduced YGTSS scores in 10 children with TS, following 
10 sessions of SMA stimulation. Tic reductions were still 
apparent at a 12 week follow-up and measures of general 
well-being were also significantly improved. A similar find-
ing was published by Le et al. (2013) who reported a signifi-
cant reduction in YGTSS scores following 20 days of rTMS 
in 25 children (that lasted up to 6 months in some cases); and 
by Mantovani et al. (2006) who reported significant reduc-
tions in YGTSS scores following 10 days of stimulation in 
5 adults/adolescents, in addition to reductions in measures 
of OCD symptoms (Y-BOCS). In a smaller scale study with 
two participants, Mantovani et al. (2007) found reductions 
in YGTSS, Y-BOCS, and measures of ADHD (ADHD-RS) 
following 10 sessions of 1 Hz rTMS at 110%RMT over the 
SMA. Using similar parameters Singh et al. (2018) also 
reported substantial decreases in YGTSS scores in two third 
of participants. An additional study by Blochet al. (2016b) 
failed to find significant changes in YGTSS measures in 12 
participants following 20 sessions of 1 Hz rTMS; however, 
in a subgroup of 6 participants who also had OCD, signifi-
cant reductions in both YGTSS and YBOCS were found. 
More recently, a study by Kahl et al. (2021) demonstrated 
significant reductions in YGTSS scores in 10 children fol-
lowing 15 sessions of SMA stimulation.
Although the research discussed above appears promis-
ing, it should be noted that a few sham-controlled studies 
have yet been conducted. One notable exception is a study 
by Landeros-Weisenberger et al. (2015), in which the effects 
of 15 days of 1HZ rTMS on YGTSS scores were shown 
to be similar between sham stimulation and active stimula-
tion conditions. Interestingly, the subset of participants who 
experienced an additional 3 weeks of active stimulation as 
part of the open-label phase of the study went on to show 
significant changes from baseline. At the time of writing, a 
single additional sham-controlled study targeting the SMA 
had been published by Wu et al. (2014), in which six partici-
pants experienced continuous theta burst stimulation (cTBS) 
over 2 days and six experienced sham stimulation. No sig-
nificant differences in tic severity measured by YGTSS were 
found. Interestingly, fMRI BOLD response during a simple 
finger tapping task was significantly reduced over the SMA 
and bilateral primary motor cortex after cTBS, suggesting 
that rTMS had an inhibitory effect on the targeted SMA that 
spread to the primary motor cortex, but this did not affect 
tics.
rTMS studies targeting motor, pre-frontal, and pre-motor 
regions have yielded far less promising results. In three 
sham-controlled cross-over studies, rTMS applied to these 
regions was reported to produce no significant change in 
tic severity when compared to a sham control; (Chae et al. 
2004; Munchau et al. 2002; Orth et al. 2005; Snijders et al. 
2005). Although this may suggest that these targets are less 
effective, it is important to note that these studies used sub-
stantially fewer sessions than those often used in SMA stud-
ies, and that there are several methodological differences 
between studies (please refer to Table 1 for details).
Recently, a single study has been published in which the 
parietal lobe was targeted bilaterally over ten sessions (Fu 
et al. 2021). This study reports impressive reductions in 
YGTSS scores and video analysis of tics; including signifi-
cant differences between sham and active groups. Neuro-
imaging work with fMRI has implicated the parietal lobe’s 
potential involvement in tic production (Bohlhalter et al. 
2006; Neuner et al. 2014) and it may be that this site is a 
viable and promising stimulation site.
Evidence so far: tDCS as a treatment for tics
Research exploring the use of tDCS therapeutically in indi-
viduals with TS has so far focused on protocols in which the 
cathode is placed over the SMA or motor cortex with the 
aim of reducing cortical excitability (see Table 2 for details). 
This has shown some therapeutic promise. For example, in 
a single-case study, Carvalho et al. (2015) found that tic 
severity (YGTSS) was reduced by 46% following ten ses-
sions of cathodal tDCS over the pre-SMA. These effects 
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were still present at a 6-month follow-up, and changes in 
resting-state networks were also identified. A similar result 
was demonstrated in a case study by Mrakic-Sposta et al. 
(2008) who also reported a reduction in tics following 5 days 
of cathodal tDCS applied to the left pre-motor cortex in two 
participants relative to a sham control condition. In addi-
tion, Eapen et al. (2017) reported reductions in tic and urge 
symptoms in two participants who experienced cathodal 
SMA stimulation for 6 weeks; and a single-case study by 
Tajadini et al. (2018) demonstrated sustained, beneficial, 
effects of cathodal stimulation over motor/inferior frontal 
regions. However, others have found only weak support for 
the beneficial effects of this approach. A recent study with 
three participants reported only 1 of 3 showed reduced tic 
severity after 10 sessions of cathodal pre-SMA stimulation 
(Behler et al. 2018). In addition, recent work has shown a 
small difference between tic frequency/intensity following 
SMA cathodal stimulation compared to sham stimulation, 
but no interaction and no clear effects of changes in cortical 
excitability (Dyke et al. 2019).
Overall, the evidence for the effectiveness of non-invasive 
brain stimulation to treat tics is rather mixed. Studies have 
mainly targeted cortical areas that are part of the cortico-
striatal-thalamo-cortical loop and have attempted to attenu-
ate tics by reducing the net excitability of these areas. How-
ever, a few studies have measured NIBS-induced changes 
within those targeted brain regions, and hence, it is unclear 
if the desired down-regulation of targeted areas was actually 
achieved and to what extent any relationships exist between 
physiological change in these regions and alteration in tic 
severity. This and several other important factors need to 
be considered when assessing the literature presented in 
Tables 1 and 2 and considering the future of NIBS as a ther-
apeutic intervention for TS.
Considerations for the future work
Here, we consider some of the caveats to previous NIBS 
research and make suggestions for future developments in 
the field. We focus on the use of NIBS for the treatment 
of tic disorder and the results presented in Tables 1 and 2. 
However, we note that many of these considerations are 
applicable more widely to the general study of NIBS as a 
therapeutic intervention for neuropsychiatric conditions.
Study design
Of the 13 TBS/rTMS studies identified by this review, 7 are 
exclusively open label, and most of which report signifi-
cant reductions in YGTSS scores following stimulation (see 
Table 1). Disappointingly, of the five studies targeting motor 
regions (SMA/M1) and including a sham control, none have 
provided convincing evidence for a beneficial effect of active 
stimulation. The study by Wu et al. (2014) is an interesting 
exception. Although no significant differences between sham 
and active conditions were found when assessing change in 
YGTSS scores, active stimulation resulted in significantly 
lower activation of SMA, left, and right M1 during a simple 
finger tapping task in comparison to sham. This is one of the 
few studies to attempt to record physiological change follow-
ing NIBS, and although it is unclear why this did not trans-
late into a larger reduction in YGTSS for the active group, 
it is an example of the type of study design which may be 
needed to further understand NIBS therapeutic potential.
At the time of writing, the most recent therapeutic trial 
of rTMS conducted by Fu et al. (2021) reported significant 
difference between YGTSS scores and video analysis of tics 
following bilateral stimulation of the parietal lobe. Unlike 
the previous sham-controlled trials discussed above, the dif-
ference between sham and active groups was found to be 
statistically different. This warrants further exploration and 
replication, but suggests that exploring different stimulation 
sites could be beneficial.
Although the majority of the results of sham-controlled 
studies using rTMS/TBS are discouraging, it is important 
to consider the potential impact of small sample sizes and 
methodological differences, including the age range of the 
participants (which tended to be older), stimulation site, and 
outcome measure (see separate section). It is clear that there 
is a need for large-scale randomised-controlled studies to 
be conducted. This recommendation is also true for tDCS 
studies. Of the studies reviewed, two employed a sham con-
trol (Dyke et al. 2019; Mrakic-Sposta et al. 2008). Encour-
agingly, both reported larger reductions in video recorded 
tics following cathode stimulation in comparison to sham. 
However, as previously noted, in Dyke et al. (2019), no sig-
nificant interaction between tDCS condition and time of 
measure (pre/post) was found.
NIBS in the brain at rest or during task relevant 
engagement?
The work reviewed in Tables 1 and 2 consists of studies 
conducted exclusively, while participants were at rest. In 
these studies, participants were typically asked to try to relax 
during stimulation and given no further task. The approach 
to applying NIBS at rest is worthy of consideration for three 
reasons. First, as with any TS study, the degree to which a 
true relaxed or rested stated is achieved is difficult to con-
clude, as there is always the possibility that participants 
are engaged in varying levels of tic suppression. Second, 
there is increasing evidence that the physiological effects of 
NIBS are influenced by cortical state at the time of stimula-
tion (Hsu et al. 2016; Silvanto and Pascual-Leone 2008). 
Thirdly, depending on the mechanism through which NIBS 
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approaches work, there might be substantial benefits to 
stimulation being delivered during or shortly after a par-
ticipant engages in a task that activates symptom-relevant 
neural circuits.
Relating to the first and second point made above, tic 
suppression has been shown to cause transient alterations 
in motor cortical excitability as measured by TMS (Ganos 
et al. 2018) and several lines of converging evidence sug-
gest that tic suppression influences multiple neural circuits 
(Ueda et al. 2021). Yet, controlling for this is challenging, 
and is often not discussed in NIBS-focused papers. This is 
noteworthy, as baseline cortical states have been shown to 
interact with subsequent NIBS-induced changes in corti-
cal excitability. This is most convincingly demonstrated in 
motor regions, particularly by meta-plasticity priming stud-
ies. For example, the effects of a single session of rTMS 
appear to reverse when two periods of identical stimulation 
are applied in close temporal proximity (Fricke et al. 2011; 
Monte-Silva et al. 2010; Siebner et al. 2004), and priming 
motor regions using voluntary hand movements has also 
been shown to interact with the expected effects of stimula-
tion [see (Karabanov et al. 2015)]. These studies highlight 
the complex interaction between baseline cortical activity 
states and NIBS, which are particularly pertinent when used 
to study TS ‘at rest’, given that this could mean vastly differ-
ent things for different participants. Researchers should be 
mindful of the potential effects of factors such as tic suppres-
sion, and give participants clear and consistent instructions 
relating to this.
All the studies reviewed here use NIBS approaches which 
(on average) reduce cortical excitability in healthy adults 
when applied at rest. This approach is largely underpinned 
by the assumption that a reduction in cortical excitability 
during/shortly after stimulation is necessary for clinical 
effects; however, this is rarely measured or reported. In a 
recent study, we found that despite small improvement in 
tics immediately after cathodal tDCS, there was no evidence 
of reduced cortical excitability or alterations in GABA-A 
synaptic inhibition (Dyke et al. 2019). Alterations in cortical 
excitability following cathodal tDCS are also not consist-
ently found in healthy adults (Dyke et al. 2016; Wiethoff 
et al. 2014). Yet, the relationship between the direction/mag-
nitude of change in cortical excitability following NIBS on 
target outcomes (e.g., task modulation in healthy adults/clin-
ical outcomes in TS) has not been systematically explored. 
Without this information, it is tempting to conclude that 
applying approaches which result in the largest reduction in 
cortical excitability will lead to the best clinical outcomes. 
However, depending on the exact underlying mechanisms 
through which NIBS approaches work, this is not necessar-
ily the case.
Pharmacological studies exploring the effects of rTMS 
have implicated NDMA receptors which are known to be 
linked to LTP/LTD-type effects (Huang et al. 2007), and 
evidence for the involvement of these receptors has also 
been reported for tDCS aftereffects (Liebetanz et al. 2002; 
Nitsche et al. 2003). It follows from this that therapeutically 
useful changes may occur due to the stimulated region hav-
ing strengthened/weakened synaptic connections. However, 
another interpretation of what happens during NIBS is that 
stimulation adds neural ‘noise’ and makes synaptic con-
nections more variable, and hence more likely to change in 
response to inputs, rather than simply making them stronger 
(LTP like) or weaker (LTD like). A recent study by Kozyrev 
et al. (2018) found that high-frequency (10 Hz) rTMS in cats 
increased cortical excitability and variability which, when 
paired with training using visual stimuli, enabled reorganisa-
tion of visual maps. This effect was not observed in a sham 
control condition. Following stimulation, these normally 
well-defined visual maps became more varied, in that sen-
sitivity to the orientations of visual stimuli were decreased. 
This finding is particularly striking as it suggests that NIBS 
is creating a period of enhanced plasticity, during which 
modulation of well-established neural responses is possible, 
and can be sustained for several hours. If the effect of NIBS 
is more akin to the addition of noise to sensorimotor circuits, 
then the average direction of change in cortical excitability 
may actually be of little importance. Further work is needed 
to understand how direction and magnitude of change in 
cortical excitability relate to alterations in learning/plastic-
ity. However, the findings reported by Kozyrev et al. (2018) 
suggest a potential benefit to combining NIBS with a thera-
peutically relevant task. Future work exploring therapeutic 
use of NIBS in TS may consider using NIBS as an adjunct 
to therapy, for example, pairing stimulation with a task such 
as tic suppression or habit reversal, and monitoring changes 
in cortical excitability to better understand the underlying 
effects of NIBS and how these can be optimised.
Participant demographics, intra‑subject variability, 
and identifying biomarkers
Studies exploring the therapeutic potential of NIBS in TS 
have tended to be conducted using very small sample sizes 
(see Tables 1 and 2). Furthermore, effect sizes are rarely 
reported and individual data are not routinely shown. Small 
sample sizes are a common problem more generally and 
have been raised previously as a contentious issue within 
the field (Heroux et al. 2017; Minarik et al. 2016; Polania 
et al. 2018). This could be particularly problematic for the 
research discussed here, given the heterogeneous nature 
of the participants, who vary in age, medication use, and 
co-morbidities, amongst other factors. This is particularly 
noteworthy given that even within relatively homogeneous 
groups, variability in response to NIBS is often reported.
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Variability in response to NIBS likely depends on sev-
eral factors including genetics, age, cortical excitability prior 
to stimulation, and medication use (Ridding and Ziemann 
2010). While samples are typically too small for sufficient 
subgroup analyses, a recent review paper summarising 11 
studies of rTMS/TBS found that the benefits of stimulation 
were the largest in younger individuals with concurrent 
ADHD (Grados et al. 2018), a meta-analysis conducted at a 
similar time also indicated larger outcomes in studies with 
younger participants (Hsu et al. 2018). However, the reli-
ability of these findings and reasons for this are unclear and 
warrant additional research.
A further important consideration is whether knowledge 
gained from studying the effects of NIBS in healthy partici-
pants is necessarily applicable to the potential therapeutic 
use of NIBS in clinical populations, particularly in those in 
which cortical excitability may have been altered chroni-
cally from normal levels. Specifically, applying what we 
have learned from studies of single session TMS/tDCS in 
healthy adults may not reflect what occurs in patient groups 
and/or following multiple sessions. Applying assumptions of 
frequency/polarity specific effects demonstrated in healthy 
adults could be problematic for clinical groups, particularly 
when previous research clearly indicates altered plastic-
ity within TS. Suppa et al. (2011) found that in contrast 
to control subjects, TS participants showed no change in 
cortical excitability following single sessions of iTBS and 
cTBS. Wu and Gilbert (2012) also found TS participants 
showed reduced alterations in cortical excitability imme-
diately following iTBS; and Brandt et al. (2014) reported 
reduced response to paired associative stimulation (PAS). 
Differences in the balance between physiological excitation 
and inhibition in TS (Jackson et al. 2015) and related condi-
tions such as OCD and major depressive disorder (MDD) 
(Radhu et al. 2013) are likely, and an increasing amount 
of work suggests that altered homeostatic plasticity (which 
maintains the equilibrium of neural activity) may be a fea-
ture of several clinical conditions (Karabanov et al. 2015; 
Wondolowski and Dickman 2013). These factors are highly 
likely to impact on NIBS outcomes and the degree to which 
changes in synaptic plasticity can be achieved. With a few 
notable exceptions (Kahl et al. 2021; Wu et al. 2014), a few 
studies have sought to assess physiological changes occur-
ring following NIBS interventions. Adopting a multi-faceted 
approach to therapeutic NIBS trials in which neuroimag-
ing is incorporated into the design will facilitate the goal of 
establishing not only for who NIBS works for but also why. 
Specifically, thorough assessment of baseline states, connec-
tivity, and neural anatomy may provide useful information 
in predicting positive outcomes.
In addition, although TMS and tDCS have been shown 
to be safe for pediatric populations (Allen et al. 2017; Palm 
et al. 2016), there remain considerations regarding the use of 
NIBS in this group. This may include the use of optimised 
stimulation protocols which differ from those used in healthy 
adults (Hameed et al. 2017). Extensive further research is 
likely needed to better understand synaptic plasticity and the 
effects of NIBS during typical and atypical development.
Understanding individual responses and being able to 
predict those who could benefit from NIBS is a critical step 
towards it becoming a useful therapy for TS and other condi-
tions. The success of studies aiming to identify biomarkers 
associated with symptom reduction following NIBS will be 
dependent on having adequate statistical power, and thus, 
sample size will be a key factor. Understandably, therapeu-
tic NIBS studies can be particularly difficult to recruit for, 
given the experimental nature of the treatment and the need 
for frequent visitation to treatment centres amongst other 
factors. A potential practical solution to this is to establish 
multi-site collaborations in which a standardized protocol is 
applied across numerous centres; alternatively, researchers 
could attempt and report internal replications. In the case 
of tDCS, studies making use of home application may be a 
feasible way of increasing sample size; however, it must be 
acknowledged that while home-use studies have increased 
ecological validity, a degree of experimental control is likely 
sacrificed.
Optimising stimulation parameters
As noted above, therapeutic NIBS studies tend to select 
stimulation parameters based on results from research con-
ducted in groups of healthy individuals, most often adults. 
These studies often involve applying the same stimulation 
to all individuals, an approach which ignores functional 
and anatomical differences, and is likely to minimise clini-
cal outcomes. With rTMS/TBS approaches, some degree 
of personalization is possible with respect to the intensity 
and type of stimulation to be used. This is typically chosen 
based on a percentage of an individual's motor threshold 
(MT), measured as the minimal TMS intensity which can 
be used to induce a small muscle twitch within the hand 
when TMS is applied to the relevant location in motor 
cortex. MT is known to be heavily dependent on struc-
tural features including orientation of white matter fibres 
and skull-to-cortex distance (Cukic et al. 2009; Herbsman 
et al. 2009), and hence, using this approach, it is possible 
to address important anatomical inter-subject differences. 
However, given that both factors will differ depending on 
the cortical site, this approach is imperfect. Approaches to 
adjusting MT for cortical regions outside of PMC have been 
developed (for example Stokes et al. (2005) and should be 
considered when targeting non-motor regions. Localization 
of optimal stimulation sites is another aspect of rTMS/TBS 
work which could be improved in several studies. To ensure 
adequate coil localization, use of neuro-navigation systems 
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is highly recommended. Preferably, this should be achieved 
by acquiring an anatomical scan for each participant and cre-
ating personalised targets (Julkunen et al. 2009), and when 
possible, the use of a task relevant fMRI localiser has also 
been shown to be beneficial in comparison to anatomical 
scan alone (Sack et al. 2009).
Unlike TMS approaches, tDCS does not induce action 
potentials and hence does not generate MEPs, even when 
applied over motor regions. This makes tailoring tDCS 
approaches more challenging, and as a result, many stud-
ies select a fixed intensity and a set electrode montage for 
all participants. One emerging approach for tailoring tDCS 
involves the use of computational current flow modelling 
(Bikson et al. 2012a, b; Sadleir et al. 2010). Several studies 
have suggested improved cortical targeting can be achieved 
through modelling current flow when considering optimal 
stimulation sites for the treatment of depression (Bai et al. 
2014; Csifcsak et al. 2018) and stroke (Galletta et al. 2015). 
This is yet to be explored in TS research but could prove 
beneficial in optimising electrode placement.
Choice of outcome measures
As is apparent in Tables 1 and 2, the outcome measures used 
to assess changes following NIBS in TS are diverse. Many 
of these are self-report questionnaires and semi-structured 
interviews which aim to capture changes in core tic symp-
toms and related co-morbidities. These outcome measures 
are critical given that the aim of such studies is to produce a 
meaningful reduction in clinical symptoms. However, while 
measuring change at a behavioural level is clearly the opti-
mal outcome clinically, it does not aid our understanding 
regarding what neurobiological alterations may underpin 
these effects. Depending on the measures used, it is also 
often unclear if it is tic expression that is changed or the 
urge-to-tic that has been modulated, or both. Given that 
many measures are self-report, and many studies are not 
sham controlled, it is also important to consider the potential 
impact of unconscious biases and placebo effects in these 
measures. It is also important that measures are able to cap-
ture the variable nature of tics which are known to wax and 
wane over time (Peterson and Leckman 1998). The use of 
video recording in addition to questionnaire measures can be 
helpful in addressing this issue, as it gives a more objective 
view of changes in tic frequency and intensity. However, this 
is also limited as it only captures a snapshot of tics present in 
that moment, and these are likely to vary across situations. 
The YGTSS is also limited in that its original purpose is to 
gauge tics that have occurred during the last week. This may 
make it insensitive to changes occurring on a shorter time 
scale. Careful consideration of outcome measure and, when 
possible, the use of neuroimaging approaches will be critical 
in understanding which individuals might benefit from what 
NIBS approaches, and how these benefits manifest. Specifi-
cally, the addition of appropriate neuroimaging methods 
will allow researchers to quantify physiological responses 
to NIBS including the direction and magnitude of effects, 
which will allow further exploration into how these interplay 
with changes in symptoms.
Conclusions
The evidence to date suggests that TMS and tDCS 
approaches may be helpful in reducing tics, yet there 
remains a substantial amount of further work needed for 
these approaches to reach a convincing level of supporting 
evidence. Complex interactions between clinical symptoms, 
cortical states, and the NIBS parameters require serious con-
sideration, and the field urgently needs additional studies to 
address a number of issues.
Our recommendations for future work exploring the ther-
apeutic impact of NIBS in TS are as follows:
1. There is a clear and urgent need for randomised sham-
controlled studies with increased sample sizes. Ideally, 
sample sizes should be sufficiently large to allow for 
subgroup analysis. Exploration of interactions with med-
ication use, co-morbidity, and symptom severity would 
be beneficial.
2. Researchers and clinicians should be mindful that the 
effects of a single stimulation session in healthy adults 
may not be the same as in clinical groups, in the devel-
oping brain, or following multiple sessions. Considera-
tion should be given to the potential impact of cortical 
state prior to stimulation (e.g., during tic suppression) 
and the potential benefits of pairing NIBS with a thera-
peutically relevant behavioural task.
3. When possible, the adoption of a multimodal approach is 
desirable. This could help to reveal potential biomarkers 
of NIBS effectiveness and clinical outcomes.
4. Careful consideration should be given to the selection 
of TMS and tDCS parameters, and whenever possible, 
these should be tailored to individuals. This may involve 
the use of scaling metrics and/or the use of computa-
tional current flow modelling. In TMS studies, the use 
of neuro-navigation systems is recommended, ideally in 
conjunction with individual anatomical scans and func-
tional localisers.
5. Outcome measures should be carefully considered and 
aim to capture a true reflection of alterations in tics, 
urges, and co-morbid symptoms/conditions over a sus-
tained period.
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